GlaxoSmithKline Pharmaceuticals Nigeria Ltd is partnership researchers and stakeholders in the nation’s healthcare sector to chart ways to improve research in Africa.

GSK Pharmaceuticals Nigeria’s forum on research and collaboration in Africa, held in Abuja, had in attendance over 75 renown  researchers, scholars, scientists, healthcare professionals, regulators and government representatives who shared cutting-edge expertise and research experiences that will positively impact the nation’s healthcare sector.

Managing Director of the company, Bhushan Akshikar, while explaining the importance of the event, said  it provided an opportunity to engage  researchers in Africa. He added that the engagement will help to chart a course for improved healthcare provision and posterity in the area of research and innovation.

“Our mission at GSK is to improve the quality of human lives by enabling people do more, feel better and live longer. We can only continue to achieve this by ensuring that everything we do is based on science. This is underpinned by our over billions of pounds’ investment in Research and Development as well as our partnership with 1,500 scientific and academic organisations and other companies”, he stated.

Commending GSK for its immense commitment to improving the practice of research in Africa, British High Commissioner to Nigeria, Paul Arkwright, applauded the initiative describing it as laudable,

Two recipients of GSK Non- Communicable Disease Research Grant, Dr. Dike Ojji and Dr. Dennis Shatima, shared their experiences with other researchers. While Ojji presented The CREOLE study which is the comparison of three combination therapies in lowering blood pressure in black Africans,  Shatima, who is a member of the team researching “Pneumonia Hospitalizations and Mortality in Children 3 months to 2 Years Old in Nigeria 2014 to 2019: Impact of Pneumococcal Conjugate Vaccine Ten Valent (PhiD-CV-10),” presented the work done far on behalf of the lead Principal Investigators – Professor Falade and Professor W.N Ogala.